ZIVO Bioscience, Inc. announced a private placement to issue 200,000 common shares at an issue price of $1 per share for the gross proceeds of $200,000 on December 5, 2023. The transaction included participation from an accredited investor. The common stock was not registered under the Securities Act of 1933, as amended or the securities laws of any state, and was offered and sold in reliance on the exemption from registration afforded by Section 4(2) and Regulation D (Rule 506) under the Securities Act and corresponding provisions of state securities laws, which exempts transactions by an issuer not involving any public offering.

No solicitation was made and no underwriting discounts were given or paid in connection with this transaction.